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Smortality. ROC curve analysis was performed to detect the best cut-off value of NLR
in the prediction of in-hospital mortality.
Results: The mean age of the study population was 6113.8 years (M: 30, F: 17).
Twenty-eight patients underwent operation due to type A aortic dissection. The rest of
the patients with chronic type B dissection were followed-up under medical treatment.
Nine patients died during hospitalization; higher levels of NLR was observed in these
patients compared to the patients who did survive (21.818.5 versus 8.15.6;
p¼0.008). Twelve patients (26%) had pericardial effusion on admission and NLR was
signiﬁcantly higher in these patients than the patients wihout effusion (17.310.7
versus 9.711.8; p¼0.02). Multivariate analysis showed that age 65 years, aortic
diameter 49 mm, pericardial effusion, history of smoking, systolic blood pressure
<90 mmHg were associated with in-hospital mortality. NLR value > 8 yielded an
AUC value of 0.795 (95% CI 0.623-0.966; p¼0.009) which demonstrated a sensitivity
of 78% and speciﬁcity of 65 % for the prediction of mortality.
Conclusıons: NLR may be associated with in-hospital cardiac events in patients with
acute aortic dissection.
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Background: Increased epicardial adipose tissue thickness (EATT), a component of
body visceral adiposity, has been suggested to increase the likelihood of lifetime
cardiovascular disease risk. Women with gestational diabetes mellitus (GDM) have
higher risk of developing type 2 diabetes and, consequently, a higher cardiovascular
risk. We searched if the patients with GDM have increased EATT, along with its
relation to the measures of insulin sensitivity.
Method: 96 women with GDM, 69 women with healthy pregnant aged between 19
and 44 years were enrolled. They all underwent physical examination and hormonal
and metabolic evaluation, as well as standard echocardiography and EATT. EATT
was measured by echocardiography above the free wall of the right ventricle. Age,
smoking status and pregestational body mass index (pre-BMI) were obtained. Insulin
resistance was assessed by homeostasis model assessment of insulin resistance
(HOMA-IR) formula. Kruskal-Wallis followed by Bonferroni-corrected post hoc
Mann-Whitney U tests were used to analyze the data.
Results: The women with GDM were signiﬁcantly older than the non-diabetic
pregnant women (p¼0.001). The HOMA index and basal insulin levels were signif-
icantly higher in the GDM group than the non-diabetic group (p <0.0001 and
p <0.0001, respectively). GDM subjects had higher EATT (p<0.001) but other
echocardiographic parameters were not statistically different.
Conclusıon: Thickness of the EAT is increased in patients with GDM in conjunction
with insulin resistance. Further studies are needed to clarify the relation of EATT and
cardiovascular risk in patients with GDM.Table 1
GDM Patients Non-Diabetics p
EATT (mm) 4.7  0,88 3.8  0.88 <0.001
p<0.05 is statistically signiﬁcant GDM: Gestational Diabetes Mellitus EATT: Epicardial Adipose
Tissue ThicknessPP-126
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Introductıon: Recent studies were reported on relationships of pulmonary function
with hypertension, type 2 diabetes, low density lipoprotein cholesterol, obesity and
insulin resistance as diagnostic criteria for metabolic syndrome and changes in the
pulmonary function. The purpose of this study was to investigate the associations
between components of metabolic syndrome with pulmonary function and functional
capacity.
Materıal-Methods: Twenty ﬁve subjects with metabolic syndrome (mean age:
43.3010.3 years) were included in our study. Metabolic syndrome is diagnosed on
the basis of the Asia criteria of the American Heart Association/National Heart,JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTLung, and Blood Institute. The anthropometric values (body mass index, waist and
hip circumference, waist/hip ratio, body fat percentage, lean muscle mass) of
subjects were determined. The total cholesterol, triglyceride, high-density lipo-
protein cholesterol, low-density lipoprotein cholesterol and fasting blood sugar
were measured with blood test. The vital capacity (VC), inspiratory capacity (IC),
forced vital capacity (FVC), forced expiratory volume for 1 second (FEV1), and
FEV1/ FVC ratio, maximal inspiratory and expiratory muscle strengths (MIP,
MEP) were evaluated. Functional capacity was assessed using 6-minute walk test
(6MWT) distance.
Results: Both waist circumference and waist/hip ratio were adversely correlated with
VC% (r¼,503, p¼0.01; r¼-,561, p¼0.004, respectively) and FVC% (r¼-,468,
p¼0.018; r¼.-,405, p¼0.045, respectively). There were negative relationships
between waist circumference with FEV1% (r¼-,456 p¼0.022) and hip circumference
with FEV1 (r¼-,499, p¼0.011). It was observed that there were signiﬁcant adverse
correlations between body fat percentage with MIP (r¼-,488, p¼0.013), VC (r¼-,587,
p¼0.002), IC (r¼-,398, p¼0.049), FVC (r¼-,678, p¼0.000); lean muscle mass with
MIP (r¼-,447, p¼0.025); HbA1c with MIP (r¼-,418, p¼0.038), MIP% (r¼-,488,
p¼0.013), MEP% (r¼-,464, p¼0.020). In addition, there were negative correlations
between hip circumference and body fat percentage with 6MWT distance (r¼-,521,
p¼0.03; r¼.-,730, p¼0.000, respectively) and there was positive correlation lean
muscle mass with 6MWT distance (r¼,686, p¼0.000).
Conclusıon: These results indicate that the metabolic syndrome impacts some
pulmonary function parameters, inspiratory and expiratory muscle strengths and
functional capacity negatively, Therefore, pulmonary function, inspiratory muscle
strength and functional capacity should be included in the assessments and treatments
intended for them should be included in treatment programs in patients with metabolic
syndrome.
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Objectıves: Breast cancer is the most common type of cancer in women. Treatment of
breast cancer includes surgery, chemotherapy and radiotherapy. These treatment
modalities have beneﬁcial effect on prognosis with the cost of potential serious cardiac
side effects. Cardiac effects are usually recognised after clinical symptom or sign
occurence. However, subclinical cardiac side effects can be determined by electro-
cardiography or echocardiography even in the early period. In this study we aimed to
determine the potential subclinical cardiotoxic effects of chemotherapy in patients
with breast cancer during early period.
Method: Fifty-one patients consecutively enrolled to the sudy. All patient were
diagnosed as breast cancer at oncology hospital in University of Gaziantep. All
patients were taken lower cemotherapy dosage than well known cardiac safety dosage
limits. The chemotherapy type, total dose and number of cure and region of radiation
therapy were determined in all patients. Before chemotherapy all of the patients
underwent to detailed ECG and ECHO examinations. After 6 months detailed ECG
and ECHO examinations were repeated and compared with baseline values.
Results: Our study results are as follows: statistically signiﬁcant decrease in ejection
fraction was found after treatment (62.3%3.3 versus 59.95.9%, p:0.002,).
Signiﬁcant increase in the transmitral A ﬂow velocity and signiﬁcant decrease of E / A
ratio were observed on Doppler ECHO analysis (77.419.1 cm / sec versus
86.018.0 cm / sec, p<0.001; 1.010.3 versus 0.90.2, p:0.03, respectively). On
tissue Doppler analysis we observed that signiﬁcant reduction in the value of E’ and
signiﬁcantly increase E / E’ ratio were present (12.53.6 cm / sec versus 10.72.9 cm
/ sec, p:0.001; 6.62.9 versus 7.73.3, p:0.04, respectively). On electrocardiographic
examination, heart rate was signiﬁcantly increased (8513 / min versus 8513 / min,
p:0.02), and there was prolongation of PR interval which was not reached to the
statistical signiﬁcance (14316 ms versus 14720 ms, p ¼ 0, 09).
Conclusıon: We evaluated the subclinical cardiac adverse effects of chemotherapy in
subjects with breast cancer. We found that chemotherapy has detrimental subclinical
effect on both of systolic and diastolic function in early six months period despite the
prescription of lower dosage of cemothearpy than well known cardiac safety dosage
limits. During post chemotherapy period, echocardiographic screening for subtle
change in echocardiographic parameters should alert physician for possible cardiac
toxicity of chemoradiotherapy.ERS C131
Comparison of cardiac ﬁndings before and sixth month of treatment
Before
treatment
Sixth month of
treatment p value
ECHO EF (%) 62,33,3 59,95,9 0,002
E (cm/sc) 75,817,6 77,520,9 0,55
A (cm/sc) 77,419,1 86,018,0 <0,001
E’ (cm/sc) 12,53,6 10,72,9 0,001
A’ (cm/sc) 11,52,4 11,33,0 0,58
E/A 1,010,3 0,90,2 0,03
E/E’ 6,62,9 7,73,3 0,04
ECG Rate (min) 8513 8813 0,02
PR (msc) 14316 14720 0,09
QRS (msc) 8111 8414 0,17
QT (msc) 34027 34633 0,19
QTd (msc) 129 149 0,39
Comparision Of Patients Who Developed AKI With Patients Who Did Not
Develop AKI
AKI (-)
n:494
AKI (+)
n:57 P
Age 6111,42 659,80 0.002
Female sex
n (%)
179 (36,2) 25 (43,9) 0.26
BMI 27,53,3 28,54,4 0.04
DM n (%) 152 (30,8) 23 (40,4) 0.14
HT n (%) 297 (60,1) 37 (64,9) 0,48
Smoking (%) 187 (38,1) 25 (44,8) 0.32
Prior KAG n (%) 210 (42,5) 21 (36,8) 0.41
SBP 124,5521,40 118,9526,13 0,12
DBP 73,8315,12 69,5617,43 0,08
Basal Cr 0,940,84 1,651,46 <0,001
GFR before the
procedure
99,3035,34 64,2330,98 0,008
EF 51,9310,65 45,4210,51 <0,001
ABI 1,170,12 1,220,17 0,008
ABI>1,3 n (%) 64 (13,0) 21 (36,8) <0,001
Total contrast used 96,0939,01 102,8937,40 0,21
Total procedure
time
26,4311,9 29,4712,77 0,09
Total Gensini 17,2520,68 23,6323,57 0,07
ACE _Inh/ARB n (%) 346 (70,1) 37 (64,9) 0,48
HGB 13,761,90 12,972,44 0,004
Uric acid 6,561.19 7,600,83 <0,001
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Objectıve: We aimed to evaluate the measurement of dimensions of interatrial septal
aneurysm (IASA) detected in aircrew during 5 year aircrew periodic medical
examination.
Materıal-Method: Data of23aircrew (age range23-46years)with IASA,detectedduring
periodic examination, were retrospectively collected. They were divided into 2 groups:
group 1 (pilots, n¼13) and group 2 (non-pilot aircrew, n¼10). In both groups bulging to
rightward or/and to leftward of atrial septum was measured by using transthoracic echo-
cardiography (TTE), apical 4-chamber view. The relation between the dimensions of
aneurysm and the paradoxical movement was examined and compared. Associated
diseases were also noted. Obtained data were analyzed using SPSS version 15.0.
Results: For group 1 and 2; the average ages were 35.547.39, 33.507.17; diam-
eters of aneurysm were 20.384.70 mm (10-28 mm), 21.305.64 mm (14-30 mm);
the bulging of aneurysm were 10.082.87 mm (7-17 mm), 9.304.16 mm (6-20 mm)
respectively and no statistically differences were found between them (p:0.41,
p:0.926, p:0.271). 4 aircrew out of the both groups had paradoxical movement in their
IASA. All of them were asymptomatic and none of them had cryptogenic stroke
history. TTE revealed 3 pilots and 4 non-pilots had patent foramen ovale showing left-
right shunt with 5-10 microbubble formations.
Conclusıon: Decompression sickness, microbubble formation that passes through
a defect in the interatrial septum and IASA have signiﬁcant roles in development of
stroke in aircrew. In our study we compared the dimensions of aneurysm between pilot
and non-pilot aircrew groups with IASA and didn't ﬁnd any statistically difference.
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Introductıon: Atherosclerosis and osteoporosis have been considered as seperate
disease. And the correlation between atherosclerosis and osteoporosis has been
investigated recently in a numerous clinical studies. Since the growing scientiﬁc
evidence have shown a lot of underlying parallel pathophysiological mechanisms and
due to similarity in risk factors and to treatment of one disease that affect the other,
idea has come out that this me be a single disorder. Many common risk factors for
osteoporosis and atherosclerosis can coexist together in postmenopausal women,
glucocorticoid induced osteoporosis and elderly men. As both chronic degenerative
diseases, the incidence of CVD and osteoporosis increase for both gender and with
age. The objective of this paper was to study the eventual association of joint
cardiovascular sisk risk factors and osteoprosis.
Materıal-Method: Total of 104 patients suffering from deﬁnite glucocorticoid
induced osteoporosis (GIO) and postmenopausal osteoporosis (PO) were examined
for CV risk factors, concomitant diseases and the use of glucocorticoids. Cardio-
vascular risk factors were analysed in all osteoporotic patients and distributed in
a two separate groups. The retrospective clinical study was done. There were 93
females (89,6%) and 14 males (10,4%). The average age in total was 63,16 years In
the female group the average age was 65,35 years (range 39-90y), while in the male
group it was 64,17 years (range 46 – 78y). The most frequent cause of OP was
glucocorticosteroid induced osteoporosis (GIO) observed in 71 (68,27%) of patients
and 33 (31,73%) patients with postmenopausal osteoporosis. The following
cardiovascular risk factors were determined in this study: Smoking, Arterial
Hypertension, Cholesterol, Tryglycerides, Glucocorticosteroids, diabetes, and other
concomitant diseases and BMD.C132 JACC VoResults: The results from this study have shown the signiﬁcant inﬂuence of cardio-
vascular risk factors and concomitant disorders on osteoporosis. Majority of patients
were females and within the age of approximately 65 years old. The major disorder
was rheumatoid arthritis in 52 patients and thyreoid disease was also very common.
The lipid proﬁle was increased in 61 patients, smoking in 42 individuals and arterial
hypertension in 46 patients. The glucocorticosteroid was used by more than half of the
study population in 67 patients or 65,7%.
Conclusıon: The results obtained from our study have shown that there is association
between cardiovascular risk factors and osteoporosis in lipid abnormalities, smoking,
arterial hypertension, gender, age, underlying disorders and use of corticosteroids.
This study and many other studies from other authors have brought us to conclusion
that atherosclerosis and osteoporosis may be the one single disease. More epidemi-
ological and investigative studies are needed to prove this hypothesis.
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Aim: In this study, whether ankle-brachial index (ABI) is an independent predictor for
acute kidney injury (AKI) in patients taken to the KAG laboratory for coronary
procedures is aimed.
Methods: Before the coronary procedures in KAG laboratory; serum creatine (SCr),
glomerular ﬁltration rate (GFR), and doppler derived ABI were measured in all
patients that are accepted to either Cardiology Department or Coronary Intensive Care
Unit of Necmettin Erbakan University between May 2012-March 2013. Patients’ SCr
were monitored until at least 48 hours after the procedure and increases bigger than
0.3 mg/dl in this value were considered as AKI.
Findings: The ABI means of patients who developed AKI and those who didnot were
found 1.170.12 and 1.220.17 respectively (p:0.008). ABI>1.3 is about 3 times
more in patients who developed AKI than the group did not (36.8% vs 13%,
p <0.001). In this study, independent predictors of AKI were ABI (odds: 11.4 (1.81-
72.84 with 95% CI), p¼0.01), EF (odds: 0.91 (0.85-0.98 with 95% CI), p¼0.007), and
preoperative GFR (odds: 0.96 (0.93-0.98 with 95% CI), p¼0.001)). It is determined
that ABI>1.30 shows the development of AKI with 36.8% sensitivity and 87.5%
speciﬁcity. (Positive predictive value: 25.3, negative predictive value: 92.3).
Discussions: In many previous studies, patients with increased ABI (arterial stiffness)
were detected to have an increased cardiovascular mortality incident. Increased AKI in
patients with high ABI whom are detected during this study could be a reason behind
the increase in cardiovascular mortality in this hospital.
Results: To foresee the contrast related AKI development which is a feared
complication is important and in this regard, ABI>1.3 may be a marker.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
